Aristides Capital’s Axogen AXGN Stock Holding History

Aristides Capital’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-44,900	Closed	-$325K	–	245
2024 Q2	$325K	Hold	44,900	–	–	0.09%	142
2024 Q1	$362K	Buy	+44,900	New	+$402K	0.13%	119

Other funds holding AXGN

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Aristides Capital's AXGN Position: Q1 2022 in Review

Aristides Capital sold out of Axogen (AXGN) in Q1 2022, closing a stake of 26,610 shares — an estimated $249K sold.

Aristides Capital first reported a position in AXGN in Q4 2021 and held it in 1 quarter. The position peaked at $249K in Q4 2021. 132 funds tracked by Wall St. Rank hold AXGN as of Q1 2022.

Aristides Capital reported no remaining Axogen position as of Q1 2022 after selling out during the quarter.
Aristides Capital sold 26,610 Axogen shares in Q1 2022, an estimated $249K.
Aristides Capital first reported a position in Axogen in Q4 2021 and held it in 1 quarter.
Aristides Capital's Axogen position peaked at $249K in Q4 2021.
132 funds tracked by Wall St. Rank held Axogen as of Q1 2022.

Based on Aristides Capital's 13F filing for Q1 2022, filed 16 May 2022.